Shen Songcui, Xie Yichen, Ju Pengliang, Li Wenzhao, Zhang Jiayuan, Cai Ruxin, Li Ruogu
Department of Cardiac Function, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Department of Radiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
J Gastrointest Oncol. 2022 Jun;13(3):923-934. doi: 10.21037/jgo-22-371.
The J wave syndromes (JWS) could be observed in patients with mediastinal tumors, though few studies have verified the statistical correlation between J waves and cardiac compression by tumors. This study aimed to investigate the relationship between J waves and cardiac compression by esophageal tumor and to compare the prediction of J waves on clinical prognosis with that of cardiac compression by esophageal tumor.
We enrolled 273 patients (228 males, 45 females; mean 63.8±7.5 years) with esophageal tumors admitted to Shanghai Chest Hospital between August 2016 and November 2020. The J wave was defined as a J-point elevation of ≥0.1 mV in a 12-lead electrocardiogram (ECG) and classified into multiple types. Chest computed tomography (CT) was reviewed to clarify the anatomical relationship between the heart and the esophageal tumor. The prognosis of severe cardiac events and survival status were followed up through medical history, examination records and telephone records.
J waves were present in 141 patients among all 273 cases. The sensitivity and specificity of cardiac compression by the tumor for J waves were 78.1% and 67.3%, respectively. The odds ratio (OR) of cardiac compression by the tumor to J waves was 7.33 [95% confidence interval (CI): 4.21-12.74; P<0.001]. The Kappa coefficient between J waves and cardiac compression was 0.44±0.05. The significance association between J waves and cardiac compression was independent from other clinical variables (P<0.001). Decreased J wave amplitude was correlated with the disappearance of cardiac compression during follow-up (P=0.03). Patients with J waves had a higher risk of severe cardiac events than those without J waves (OR =2.84, 95% CI: 1.22-6.63; P=0.01). During the follow-up period, we found that the presence of J waves [hazard ratio (HR) =2.28; 95% CI: 1.35-3.84; P=0.002] and cardiac compression by the tumor (HR =2.51; 95% CI: 1.51-4.17; P<0.001) were both negatively correlated with the survival time of patients.
The presence of J waves could be used as an effective mean to predict the mechanical impact of esophageal tumor on the heart, and played an important role in predicting the survival of patients.
纵隔肿瘤患者中可观察到J波综合征(JWS),但很少有研究证实J波与肿瘤所致心脏受压之间的统计学相关性。本研究旨在探讨J波与食管肿瘤所致心脏受压之间的关系,并比较J波对临床预后的预测与食管肿瘤所致心脏受压的预测。
我们纳入了2016年8月至2020年11月期间入住上海胸科医院的273例食管肿瘤患者(男228例,女45例;平均年龄63.8±7.5岁)。J波定义为12导联心电图(ECG)中J点抬高≥0.1 mV,并分为多种类型。回顾胸部计算机断层扫描(CT)以明确心脏与食管肿瘤之间的解剖关系。通过病史、检查记录和电话记录随访严重心脏事件的预后和生存状况。
273例患者中141例出现J波。肿瘤所致心脏受压对J波的敏感性和特异性分别为78.1%和67.3%。肿瘤所致心脏受压与J波的比值比(OR)为7.33[95%置信区间(CI):4.21-12.74;P<0.001]。J波与心脏受压之间的Kappa系数为0.44±0.05。J波与心脏受压之间的显著关联独立于其他临床变量(P<0.001)。随访期间J波振幅降低与心脏受压消失相关(P=0.03)。有J波的患者发生严重心脏事件的风险高于无J波的患者(OR =2.84,95%CI:1.22-6.63;P=0.01)。在随访期间,我们发现J波的存在[风险比(HR)=2.28;95%CI:1.35-3.84;P=0.002]和肿瘤所致心脏受压(HR =2.51;95%CI:1.51-4.17;P<0.001)均与患者的生存时间呈负相关。
J波的存在可作为预测食管肿瘤对心脏机械性影响的有效手段,并在预测患者生存方面发挥重要作用。